Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 1958 entries
View as:

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00063401 Org: User:
Start: 09/30/03 End: 06/30/06 Due: 06/30/07

Study of FORTEO Use in Subjects in the Community Setting

Phase: N/A Priority: Normal
NCT ID: NCT01078805 Org: User:
Start: 08/31/03 End: 02/28/11 Due: 02/28/12

A Study of Olanzapine in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00970281 Org: User:
Start: 09/30/09 End: 04/30/11 Due: 04/30/12

A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05630274 Org: User:
Start: 04/16/19 End: 06/21/19 Due: 06/21/20

A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT04004611 Org: User:
Start: 05/18/20 End: 03/15/23 Due: 03/15/24

Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01662817 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06181084 Org: User:
Start: 10/11/21 End: 04/28/22 Due: 04/28/23

Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06598631 Org: User:
Start: 10/09/24 End: 12/30/24 Due: 12/30/25

A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01871493 Org: User:
Start: 06/30/13 End: 09/30/13 Due: 09/30/14

A Study of LY2922083 in Healthy Participants and Participants With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01748552 Org: User:
Start: 12/31/12 End: 08/31/13 Due: 08/31/14

A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China

Phase: N/A Priority: Normal
NCT ID: NCT01931475 Org: User:
Start: 09/30/13 End: 06/30/15 Due: 06/30/16

A Study of Galcanezumab in Participants With Chronic Cluster Headache

Phase: N/A Priority: Normal
NCT ID: NCT02438826 Org: User:
Start: 06/18/15 End: 08/14/19 Due: 08/14/20

Study of Duloxetine in Elderly Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00062673 Org: User:
Start: 03/31/03 End: 07/31/04 Due: 07/31/05

A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)

Phase: N/A Priority: Normal
NCT ID: NCT04849416 Org: User:
Start: 05/14/21 End: 12/31/25 Due: 12/31/26

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

Phase: N/A Priority: Normal
NCT ID: NCT05508789 Org: User:
Start: 10/10/22 End: 07/31/28 Due: 07/31/29

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06937099 Org: User:
Start: 06/30/25 End: 05/31/28 Due: 05/31/29

Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00586508 Org: User:
Start: 11/30/07 End: 10/31/13 Due: 10/31/14

A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)

Phase: N/A Priority: Normal
NCT ID: NCT03267732 Org: User:
Start: 09/05/17 End: 10/30/17 Due: 10/30/18

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02106364 Org: User:
Start: 02/28/15 End: 06/30/16 Due: 06/30/17

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

Phase: N/A Priority: Normal
NCT ID: NCT00666757 Org: User:
Start: 05/31/08 End: 03/31/09 Due: 03/31/10

A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00702650 Org: User:
Start: 06/30/08 End: 07/31/09 Due: 07/31/10

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT03570749 Org: User:
Start: 09/24/18 End: 01/29/25 Due: 01/29/26

A Study of Continuous Heart Rate Monitoring in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04682184 Org: User:
Start: 01/27/21 End: 03/25/21 Due: 03/25/22

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).

Phase: N/A Priority: Normal
NCT ID: NCT05620576 Org: User:
Start: 11/14/22 End: 08/01/23 Due: 08/01/24

A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05469113 Org: User:
Start: 01/29/19 End: 03/05/19 Due: 03/05/20